Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Megadeth's Dave Mustaine diagnosed with throat cancer; band cancels 2019 shows

Published 06/17/2019, 05:27 PM
Updated 06/17/2019, 05:30 PM
© Reuters. FILE PHOTO: Members of Megadeth hold the award for Best Metal Performance for "Dystopia" at the 59th Annual Grammy Awards in Los Angeles

LOS ANGELES (Reuters) - Dave Mustaine, lead singer and guitarist for the heavy metal band Megadeth, has been diagnosed with throat cancer, forcing the band to cancel most of its 2019 shows, he said on Monday.

Megadeth had been scheduled to perform this year in Milwaukee, Las Vegas, Buenos Aires and other cities in North and South America.

"I'm working closely with my doctors, and we've mapped out a treatment plan which they feel has a 90% success rate," Mustaine said in a statement on Facebook (NASDAQ:FB). "Treatment has already begun."

Megadeth, which was formed in 1983 and helped pioneer a style called thrash metal, reached the height of its popularity in the late 1980s and 1990s with albums such as "Countdown to Extinction" and "Youthanasia." Mustaine is known for his shredding, a fast style of rock lead guitar playing.

Mustaine, 57, and his bandmates were in the studio working on a follow-up to their 2016 album "Dystopia," the singer said, adding he could not "wait for everyone to hear" it.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.